M&A Deal Summary |
|
---|---|
Date | 2016-03-31 |
Target | Florida Biologix |
Sector | Life Science |
Buyer(s) | Brammer Bio |
Sellers(s) | Ampersand Capital Partners |
Deal Type | Merger |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2015 |
Sector | Life Science |
Brammer Biopharmaceuticals LLC was founded early in 2015 to create a best-in-class cell and gene therapy contract development and manufacturing organization (CDMO) to enable large pharma and biotech clients to accelerate the delivery of novel medicines to improve patient health. With the in-depth biologics manufacturing knowledge and expertise of founders Mark Bamforth (CEO) and Steven Kasok (CFO), previously cofounders of Gallus Biopharmaceuticals, now as Brammer Bio, the company is positioned to accelerate the development of these important emerging technologies.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Merger) | 1 of 1 |
State (Florida) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2016) | 1 of 1 |
Category | Growth Capital Firm |
---|---|
Founded | 1988 |
PE ASSETS | 3.0B USD |
Size | Large |
Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 26 of 55 |
Sector (Life Science) | 11 of 25 |
Type (Merger) | 2 of 4 |
State (Florida) | 1 of 1 |
Country (United States) | 26 of 51 |
Year (2016) | 4 of 9 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2016-03-24 |
Magellan Biosciences
Chelmsford, Massachusetts, United States Magellan Biosciences, Inc. is a developer and manufacturer of FDA-cleared products for the testing of blood to diagnose lead poisoning in children and adults. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2016-08-09 |
Biomedical Structures
Warwick, Rhode Island, United States Biomedical Structures LLC is a developer and manufacturer of biomedical textile implants, while MPC focuses on the development and manufacturing of precise polymer components. |
Sell | - |